328
Participants
Start Date
March 31, 2008
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
Aliskiren
Aliskiren supplied in 150 mg and 300 mg tablets.
Placebo to Aliskiren
Placebo to Aliskiren matching 150 and 300 mg tablets
Investigative Site, Zanesville
Investigative Site, Frankfurt
Investigative Site, Valencia
Lead Sponsor
Novartis
INDUSTRY